It is hypothesized that imagery rescripting and imaginal exposure therapy are both effective in the treatment of nightmare disorder. Whereas it is expected that the two therapies will both be effective in the treatment of nightmares, it might be…
ID
Bron
Aandoening
Nightmares (Nachtmerries); Imagery rescripting therapy (Imagery rescripting therapie); Imaginal exposure therapy (Imaginaire exposure therapie)
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Nightmare frequency
2. Nightmare distress
Achtergrond van het onderzoek
The proposed study aims at investigating the effectivity of two CBT-based treatments for nightmares (i.e., imagery rescripting and imaginal exposure), as well as possible working mechanisms underlying these therapeutic techniques.
Doel van het onderzoek
It is hypothesized that imagery rescripting and imaginal exposure therapy are both effective in the treatment of nightmare disorder.
Whereas it is expected that the two therapies will both be effective in the treatment of nightmares, it might be possible that the therapies work through different mechanisms. The current study aims at exploring the working mechanisms of the two therapies by assessing the effects of several proposed mediators (see 'secondary outcome measures') of the treatment effect (see 'primary outcome measures').
Onderzoeksopzet
(1) Pre-assessment ; (2, 3, 4) treatment sessions; (5) Post-assessment ; (6) 3-months follow-up ; (7) 6-months follow-up
Onderzoeksproduct en/of interventie
Both active interventions will be delivered by trained and experienced therapists.
Imagery rescripting (IR) therapy: participants will receive an adapted 3-session intervention of the original IR protocol by Arntz en Weertman (1999). Here, the script of a nightmare is actively changed in the imagination of the participant, after the original nightmare has been reactivated.
Imaginal exposure (IE) therapy: participants will receive 3 sessions of a standard IE intervention (Foa & Rothbaum, 1989). Here, the nightmare is reactivated and subsequently re-lived in the participants’ imagination, until the emotions accompanied by the nightmare become tolerable.
Wait-list control condition: 5 weeks. Note that after the waiting period, participants will receive either one of the active treatments (by randomization). Here, treatment will be delivered by unexperienced therapists (e.g., students). Primary and secondary outcome measures (but no mediators of the treatment effect) will be assessed at time points 1 and 5 to investigate whether the treatment effects found in the main study (i.e., treatment delivered by experienced therapists) can be replicated with a group of unexperienced therapists.
Publiek
Jaap Lancee
Weesperplein 4
Amsterdam 1018XA
The Netherlands
020-5258609
j.lancee@uva.nl
Wetenschappelijk
Jaap Lancee
Weesperplein 4
Amsterdam 1018XA
The Netherlands
020-5258609
j.lancee@uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
18 years of age or older; one or more nightmare(s) per week, with a recurrent (emotional) theme; nightmares have to impair the daily functioning of the client (nightmare disorder according to DSM-5); fluency in Dutch
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
A current diagnosis of alcohol and/or drug abuse or dependency; PTSD resulting from protracted and recurring trauma (type 2 trauma); psychotic disorder; CBT-based psychotherapy for nightmare symptoms in the preceding 12 months; Co-morbidity as such will not be reason for exclusion but the nightmares must be the principal diagnosis. If applicable, participants will be asked to keep their medication intake stable during and 1-8 weeks before treatment (depending on the type of medication).
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4828 |
NTR-old | NTR4951 |
Ander register | - : 2014-CP-3794 |